Karen Weintraub December 15, 2015 There are no industry-wide figures on how many scientists are leaving top-level academic positions to lead research units at drug companies, but anecdotal evidence suggests a recent surge. James Bradner (Dana-Farber) is mentioned.Read the full article
The Economic Forces That Drive Prescription Drug Prices October 30, 2025 Luca Maini on what new U.S. policies could mean for patients and health systems
HMS Announces Blavatnik Institute Early Career Investigator Awards November 6, 2025 10 projects receive basic and translational research funding
CTE Is Caused by More Than Head Trauma, New Study Suggests October 30, 2025 Research reveals Alzheimer’s disease-like DNA damage, hints at immune involvement
